Stoke prepares for IND, IPO with $90M series B

Stoke Therapeutics Inc. (Bedford, Mass.) is eyeing an IPO next half after raising $90 million in a series B round from a slew of new investors.


Read the full 270 word article

How to gain access

Continue reading with a
two-week free trial.